Home » Topics » Regulatory

Regulatory
RSS

FDA approves Enbrel to treat children with moderate to severe plaque psoriasis

Nov. 7, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

FDA issues new approvals in NSCLC for Keytruda

Oct. 25, 2016

FDA approves Zinplava to reduce recurrence of C. difficile infection

Oct. 24, 2016

FDA grants accelerated approval for Lartruvo in soft tissue sarcoma

Oct. 20, 2016

FDA approves Tecentriq for metastatic NSCLC

Oct. 19, 2016

FDA approves infant-specific dose of Pertzye

Oct. 13, 2016

FDA approves Carnexiv as intravenous short-term replacement therapy for seizures

Oct. 10, 2016

Micatrio approved in Japan for hypertension

Oct. 3, 2016

Mikeluna approved in Japan for glaucoma and intraocular hypertension

Sep. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...